Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa
- PMID: 22150449
- PMCID: PMC3310261
- DOI: 10.1111/j.1530-0277.2011.01669.x
Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa
Abstract
Background: Alcohol is heavily consumed in sub-Saharan Africa and affects HIV transmission and treatment and is difficult to measure. Our goal was to examine the test characteristics of a direct metabolite of alcohol consumption, phosphatidylethanol (PEth).
Methods: Persons infected with HIV were recruited from a large HIV clinic in southwestern Uganda. We conducted surveys and breath alcohol concentration (BRAC) testing at 21 daily home or drinking establishment visits, and blood was collected on day 21 (n = 77). PEth in whole blood was compared with prior 7-, 14-, and 21-day alcohol consumption.
Results: (i) The receiver operator characteristic area under the curve (ROC-AUC) was highest for PEth versus any consumption over the prior 21 days (0.92; 95% confidence interval [CI]: 0.86 to 0.97). The sensitivity for any detectable PEth was 88.0% (95% CI: 76.0 to 95.6) and the specificity was 88.5% (95% CI: 69.8 to 97.6). (ii) The ROC-AUC of PEth versus any 21-day alcohol consumption did not vary with age, body mass index, CD4 cell count, hepatitis B virus infection, and antiretroviral therapy status, but was higher for men compared with women (p = 0.03). (iii) PEth measurements were correlated with several measures of alcohol consumption, including number of drinking days in the prior 21 days (Spearman r = 0.74, p < 0.001) and BRAC (r = 0.75, p < 0.001).
Conclusions: The data add support to the body of evidence for PEth as a useful marker of alcohol consumption with high ROC-AUC, sensitivity, and specificity. Future studies should further address the period and level of alcohol consumption for which PEth is detectable.
Copyright © 2011 by the Research Society on Alcoholism.
Figures
Similar articles
-
Phosphatidylethanol confirmed alcohol use among ART-naïve HIV-infected persons who denied consumption in rural Uganda.AIDS Care. 2017 Nov;29(11):1442-1447. doi: 10.1080/09540121.2017.1290209. Epub 2017 Feb 13. AIDS Care. 2017. PMID: 28278568 Free PMC article.
-
Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda.PLoS One. 2014 Dec 1;9(12):e113152. doi: 10.1371/journal.pone.0113152. eCollection 2014. PLoS One. 2014. PMID: 25436894 Free PMC article.
-
Associations Between the Phosphatidylethanol Alcohol Biomarker and Self-Reported Alcohol Use in a Sample of HIV-Infected Outpatient Drinkers in Western Kenya.Alcohol Clin Exp Res. 2016 Aug;40(8):1779-87. doi: 10.1111/acer.13132. Epub 2016 Jul 18. Alcohol Clin Exp Res. 2016. PMID: 27426424 Free PMC article. Clinical Trial.
-
Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse.Drug Test Anal. 2011 Apr;3(4):195-200. doi: 10.1002/dta.278. Epub 2011 Mar 25. Drug Test Anal. 2011. PMID: 21438164 Review.
-
[Phosphatidylethanol blood analysis].Ann Biol Clin (Paris). 2019 Dec 1;77(6):638-644. doi: 10.1684/abc.2019.1499. Ann Biol Clin (Paris). 2019. PMID: 31859640 Review. French.
Cited by
-
Alcohol use, depressive symptoms, and intimate partner violence perpetration: A longitudinal analysis among men with HIV in northern Vietnam.PLoS One. 2020 Oct 16;15(10):e0240674. doi: 10.1371/journal.pone.0240674. eCollection 2020. PLoS One. 2020. PMID: 33064780 Free PMC article.
-
Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected.J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):135-143. doi: 10.1097/QAI.0000000000001588. J Acquir Immune Defic Syndr. 2018. PMID: 29112041 Free PMC article.
-
Prevalence of, and factors associated with, alcohol use disorder among young adults (aged 15-24 years) living with HIV/AIDS in low-income and middle-income countries: protocol for a systematic review.BMJ Open. 2023 Jan 4;13(1):e068108. doi: 10.1136/bmjopen-2022-068108. BMJ Open. 2023. PMID: 36599636 Free PMC article.
-
Secondary Analysis of a Randomized Clinical Trial of Naltrexone Among Women Living With HIV: Correlations Between Reductions in Self-Reported Alcohol Use and Changes in Phosphatidylethanol.Alcohol Clin Exp Res. 2021 Jan;45(1):174-180. doi: 10.1111/acer.14515. Epub 2020 Dec 17. Alcohol Clin Exp Res. 2021. PMID: 33190242 Free PMC article. Clinical Trial.
-
A Brief Alcohol Intervention (BAI) to reduce alcohol use and improve PrEP outcomes among men who have sex with men in Vietnam: study protocol for a randomized controlled trial.Trials. 2024 Aug 21;25(1):552. doi: 10.1186/s13063-024-08382-5. Trials. 2024. PMID: 39164770 Free PMC article.
References
-
- The World Health Report 2000 -- Health Systems: Improving Performance. WHO; Geneva: 2000. - PubMed
-
- East African Breweries Limited; 2011a.
-
- Global Status Report on Alcohol and Health. World Health Organization; Geneva: 2011b.
-
- Aalto M, Alho H, Halme JT, Seppa K. AUDIT and its abbreviated versions in detecting heavy and binge drinking in a general population survey. Drug Alcohol Depend. 2009;103:25–9. - PubMed
-
- Acuda SW, Sebit MB. Prevalence of psychoactive substance use among psychiatric in-patients in Harare, Zimbabwe. Cent Afr J Med. 1997;43:226–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials